Quest Diagnostics Incorporated
DGX
$190.18
$0.370.20%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.28B | 11.04B | 10.85B | 10.52B | 10.16B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.28B | 11.04B | 10.85B | 10.52B | 10.16B |
| Cost of Revenue | 7.52B | 7.36B | 7.22B | 7.03B | 6.80B |
| Gross Profit | 3.75B | 3.68B | 3.63B | 3.50B | 3.36B |
| SG&A Expenses | 1.96B | 1.92B | 1.89B | 1.83B | 1.76B |
| Depreciation & Amortization | 152.00M | 154.00M | 154.00M | 147.00M | 137.00M |
| Other Operating Expenses | 1.00M | 3.00M | 5.00M | 3.00M | 2.00M |
| Total Operating Expenses | 9.63B | 9.43B | 9.27B | 9.01B | 8.69B |
| Operating Income | 1.65B | 1.60B | 1.58B | 1.52B | 1.46B |
| Income Before Tax | 1.40B | 1.36B | 1.33B | 1.29B | 1.21B |
| Income Tax Expenses | 329.00M | 314.00M | 301.00M | 289.00M | 266.00M |
| Earnings from Continuing Operations | 1.08K | 1.05K | 1.03K | 1.00K | 948.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -51.00M | -54.00M | -57.00M | -54.00M | -51.00M |
| Net Income | 1.02B | 992.00M | 969.00M | 950.00M | 897.00M |
| EBIT | 1.65B | 1.60B | 1.58B | 1.52B | 1.46B |
| EBITDA | 2.22B | 2.17B | 2.14B | 2.06B | 1.98B |
| EPS Basic | 9.17 | 8.86 | 8.63 | 8.47 | 8.02 |
| Normalized Basic EPS | 7.64 | 7.40 | 7.19 | 6.92 | 6.70 |
| EPS Diluted | 9.07 | 8.77 | 8.55 | 8.38 | 7.94 |
| Normalized Diluted EPS | 7.56 | 7.32 | 7.10 | 6.83 | 6.61 |
| Average Basic Shares Outstanding | 445.00M | 446.00M | 446.00M | 446.00M | 445.00M |
| Average Diluted Shares Outstanding | 450.00M | 451.00M | 452.00M | 452.00M | 451.00M |
| Dividend Per Share | 3.26 | 3.20 | 3.15 | 3.10 | 3.05 |
| Payout Ratio | 34.86% | 35.58% | 35.81% | 36.00% | 37.46% |